Gelex

Commission Decision of 21 October 2008 laying down standard reporting requirements for national programmes for the eradication, control and monitoring of certain animal diseases and zoonoses co-financed by the Community (notified under document number C(2008) 6032) (Text with EEA relevance) (2008/940/EC)

In forceVersion 2008-10-21
Grade B

mapped from publisher markup. A grade says how a document's structure was obtained, not how reliable the law is.

Ask Gelex about this law

Address https://gelex.eu/eli/EU/decision/2008/940@2008-10-21/en

Contents
  1. Preamble
    1. Article 1
    2. Article 2
    3. Article 3
    4. Article 4
    5. Article 5
    6. Article 6
    7. Article 7
  2. ANNEX
  3. ANNEX I REQUIREMENTS FOR INTERMEDIATE TECHNICAL AND FINANCIAL EVALUATION
  4. 1.
  5. ANNEX II DATA ON HERDS (one table per disease/species)
  6. ANNEX III DATA ON ANIMALS (one table per disease/species)
  7. ANNEX IV DATA ON VACCINATION PROGRAMMES (one table per disease/species)
  8. ANNEX V DATA ON STATUS OF HERDS AT THE END OF THE PERIOD (one table per disease/species)
  9. ANNEX V.A DATA ON ZOONOTIC SALMONELLA
  10. ANNEX VI REQUIREMENTS FOR FINAL REPORTS
  11. 2.
  12. 3.
  13. ANNEX VII INTERMEDIATE/FINAL FINANCIAL REPORT AND PAYMENT APPLICATION (one table per disease/zoonoses/species)
  14. ANNEX VII.A
  15. ANNEX TO THE FINAL FINANCIAL REPORT FOR PIGS PROGRAMMES Aujesky’s disease — Classical swine fever — African swine fever — Swine vesicular disease
  16. ANNEX VII.B
  17. ANNEX TO THE FINAL FINANCIAL REPORT FOR BLUETONGUE PROGRAMME Bluetongue
  18. ANNEX VII.C
  19. PART 1 Bovine brucellosis — Bovine tuberculosis — Enzootic bovine leucosis ANNEX TO THE FINAL FINANCIAL REPORT FOR BOVINE PROGRAMMES
  20. PART 2 Bovine brucellosis — Bovine tuberculosis — Enzootic bovine leucosis ANNEX TO THE FINAL FINANCIAL REPORT FOR BOVINE PROGRAMMES
  21. ANNEX VII.D
  22. PART 1 Ovine and caprine brucellosis ANNEX TO THE FINAL FINANCIAL REPORT FOR B. MELITENSIS PROGRAMME
  23. PART 2 Ovine and caprine brucellosis ANNEX TO THE FINAL FINANCIAL REPORT FOR MELITENSIS PROGRAMME
  24. ANNEX VII.E
  25. ANNEX TO THE FINAL FINANCIAL REPORT FOR RABIES PROGRAMME Rabies
  26. ANNEX VII.F
  27. PART 1 Salmonella ANNEX TO THE FINAL FINANCIAL REPORT FOR SALMONELLA PROGRAMME
  28. PART 2 Salmonella ANNEX TO THE FINAL FINANCIAL REPORT FOR SALMONELLA
  29. ANNEX VIII INTERMEDIATE/FINAL TECHNICAL AND FINANCIAL REPORT AND PAYMENT APPLICATIONS Table A Table B
  30. ANNEX IX INTERMEDIATE/FINAL TECHNICAL AND FINANCIAL REPORT AND PAYMENT APPLICATIONS
  31. PART A Table 1 Table 2 Table 3 Poultry holdings (except ducks and geese) sampled Serological investigation according to point B of Annex I to Commission Decision 2007/268/EC on holdings of broilers (only when at risk)/fattening turkeys/chicken breeders/turkey breeders/laying hens/free range laying hens/ratites/farmed feathered game (pheasants, partridges, quails …)/backyard flocks/others (keep as appropriate) PLEASE USE ONE FORM PER POULTRY CATEGORY Duck and geese holdings sampled according to point C of Annex I to Decision 2007/268/EC Serological investigation Wild birds — investigation according to the surveillance programme for avian influenza in wild birds set out in Annex II to Decision 2007/268/EC
  32. PART B Avian influenza
  33. ANNEX X INTERMEDIATE/FINAL TECHNICAL AND FINANCIAL REPORT
  34. PART A 1.1.1.1.2.1.3. 2.2.1.2.2.2.3. 3. 4.
  35. PART B Table A 1.1.1.1.2.1.3.2.2.1.2.2.2.3.2.4.3.3.1.3.2.3.3.3.4.3.5.4.5.6.7. Detailed analysis of the cost of the programme

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Council Decision 90/424/EEC of 26 June 1990 on expenditure in the veterinary field, and in particular Article 24(10) thereof,

Whereas:

(1) Decision 90/424/EEC lays down the procedures governing the Community’s financial contribution towards the programmes for the eradication, control and monitoring of animal diseases and zoonoses.

(2) Pursuant to Article 24(1) of Decision 90/424/EEC, a Community financial measure is to be introduced to reimburse the expenditure incurred by the Member States for the financing of national programmes for the eradication, control and monitoring of the animal diseases and zoonoses listed in the Annex to that Decision.

(3) Following the adoption of Commission Decision 2008/341/EC of 25 April 2008 laying down Community criteria for national programmes for the eradication, control and monitoring of certain animal diseases and zoonoses and in order to further improve the process of submission, approval and assessment of progress during the implementation of the programmes, Commission Decision 2008/425/EC of 25 April 2008 laying down standard requirements for the submission by Member States of national programmes for the eradication, control and monitoring of certain animal diseases and zoonoses for Community financing has updated those standard requirements to make them consistent with those criteria.

(4) Point 7(e) of the Annex to Decision 2008/341/EC provides that eradication programmes submitted by the Member States to the Commission for co-financing are to contain rules for adequate compensation to farmers for animals which have to be slaughtered or culled in the framework of the programme and for the products which have to be destroyed.

(5) It is appropriate to provide that in the absence of such rules compensation should be paid within 90 days, in order to avoid reduction in Community financial support.

(6) Decision 90/424/EEC provides that Member States are to submit, for each approved programme, intermediate technical and financial reports and, by 30 April each year at the latest, an annual detailed technical report, including the assessment of the results achieved and a detailed account of expenditure incurred for the previous year.

(7) An evaluation system is in place for the purposes of assessing progress made during implementation of eradication and control programmes. The evaluation system includes a reporting system to provide epidemiological data from the programmes based on Commission Decision 2002/677/EC of 22 August 2002 laying down standard reporting requirements for programmes of eradication and control of animal diseases co-financed by the Community and repealing Decision 2000/322/EC.

(8) Following the adoption of Decision 2008/425/EC, harmonisation of the reporting system is desirable and Decision 2002/677/EC should be repealed and replaced by this Decision.

(9) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,

HAS ADOPTED THIS DECISION:

Article 1

Member States shall, in accordance with this Decision, submit intermediate and final reports as regards eradication, control and monitoring programmes adopted pursuant to Article 24 of Decision 90/424/EEC.

Article 2

For the purpose of this Decision, the following definitions shall apply:

(a) intermediate reports means intermediate technical and financial reports evaluating the running programmes, to be submitted to the Commission as provided for in Article 24(7)(a) of Decision 90/424/EEC;

(b) final reports means detailed technical and financial reports to be submitted to the Commission by 30 April each year at the latest for the entire year of application of the programmes, as provided for in Article 24(7)(b) of Decision 90/424/EEC;

(c) payment applications means the payment applications relating to the expenditure incurred by a Member State, to be submitted to the Commission, as provided for in Article 24(8) of Decision 90/424/EEC.

Article 3

1. With regards to running programmes approved for Community co-financing in accordance with Article 24(5) of Decision 90/424/EEC, an intermediate report shall be submitted to the Commission by 31 July each year at the latest.

2. The intermediate reports shall include:

(a) in respect of bovine tuberculosis, bovine brucellosis, ovine and caprine brucellosis (B. melitensis), Enzootic Bovine Leucosis (EBL), Aujesky’s disease, Bluetongue in endemic or high risk areas, African swine fever, swine vesicular disease, classical swine fever, Anthrax, Contagious bovine pleuropneumonia, Echinococcosis, Trichinellosis, Verotoxigenic E. coli, all the relevant information, including at least, the information specified in Annexes I, II, III IV and VII, as appropriate;

(b) in respect of rabies, all the relevant information, including at least, the information specified in Annexes I and VII, as appropriate;

(c) in respect of Salmonellosis (zoonotic salmonella), all the relevant information, including at least, the information specified in Annexes I, V.A and VII as appropriate;

(d) in respect of Transmissible spongiform encephalopathies (TSE), all the relevant information, including at least, the information specified in Annex VIII, as appropriate;

(e) in respect of Avian influenza in poultry and wild birds all the relevant information, including at least, the information specified in Annex IX, as appropriate;

(f) in respect of aquaculture animal diseases such as Infectious haematopoietic necrosis (IHN), Infectious salmon anaemia (ISA), Viral haemorrhagic septicæmia (VHS), Koi herpes virus infection (KHV), Infection with Bonamia ostreae, Infection with Marteilia refringens, White spot disease in crustacean, all the relevant information, including at least, the information specified in Annex X, as appropriate.

Article 4

1. Final reports shall include:

(a) in respect of bovine tuberculosis, bovine brucellosis, ovine and caprine brucellosis (B. melitensis), Enzootic Bovine Leucosis (EBL), Aujesky’s disease, Bluetongue in endemic or high risk areas, African swine fever, swine vesicular disease, classical swine fever, Anthrax, Contagious bovine pleuropneumonia, Echinococcosis, Trichinellosis, Verotoxigenic E. coli, the payment application and all relevant information, including at least, the information specified in Annexes II, III, IV, V, VI, VII and in the specific Annexes VII.A, VII.B, VII.C or VII.D, as appropriate;

(b) in respect of rabies, the payment application and all relevant information, including at least, the information specified in Annexes VII and VII.E, as appropriate;

(c) in respect of Salmonellosis (zoonotic salmonella), the payment application and all relevant information, including at least, the information specified in Annexes V.A, VI, VII and VII.F, as appropriate;

(d) in respect of Transmissible spongiform encephalopathies (TSE), the payment application and all relevant information, including at least, the information specified in Annexes VIII, as appropriate;

(e) in respect of Avian influenza in poultry and wild birds, the payment application and all relevant information, including at least, the information specified in Annexes IX, as appropriate;

(f) in respect of aquaculture animal diseases such as Infectious haematopoietic necrosis (IHN), Infectious salmon anaemia (ISA), Viral haemorrhagic septicæmia (VHS), Koi herpes virus infection (KHV), Infection with Bonamia ostreae, Infection with Marteilia refringens, White spot disease in crustaceans, the payment application and all relevant information, including at least, the information specified in Annex X, as appropriate.

2. For the purpose of completing the table laid down in Annexes VII C, D and F and without prejudice to Article 4(2) of Commission Regulation (EC) No 296/96, Member States should indicate in the column compensation the compensation granted between 1 day and 90 calendar days after the slaughter of the animal or the destruction of the products or after the presentation of the completed claim by the owner. Where the authorities concerned make compensation payments outside of the 90 days (from 91 to 210 calendar days) reduction in Community financial support shall apply.

Article 5

Decision 2002/677/EC is repealed.

Article 6

This Decision shall apply to programmes for the eradication, control and monitoring of animal diseases to be implemented as from 1 January 2009.

Article 7

This Decision is addressed to the Member States.

Done at Brussels, 21 October 2008. For the Commission Androulla Vassiliou Member of the Commission

ANNEX

ANNEX I REQUIREMENTS FOR INTERMEDIATE TECHNICAL AND FINANCIAL EVALUATION

Minimum content of the evaluation:

Member State:

Date:

Disease/zoonosis:

Animal species:

1. technical and financial evaluation:

1.

1.1. confirmation that all legislation concerning the implementation of the programme was in force at the beginning of the programme (if not, evaluation of the situation);

1.2. evaluation of the implementation of budgetary requirements necessary for the running of the programme;

1.3. estimation of the money already spent in the context of the programme for the co-financed measures;

1.4. preview of the money to be spent in the whole year under report for the co-financed measures.

ANNEX II DATA ON HERDS (one table per disease/species)

Reporting period  Intermediate report  Final report Region Total number of herds Total number of herds under the programme Number of herds checked Number of positive herds Number of new positive herds Number of herds depopulated % positive herds depopulated Indicators % herd coverage % positive herds Period herd prevalence % new positive herds Herd incidence 1 2 3 4 5 6 7 8 = (7/5) × 100 9 = (4/3) × 100 10 = (5/4) × 100 11 = (6/4) × 100 Total Total — 1

Member State:

Date:

Year:

Disease:

Animal species:

ANNEX III DATA ON ANIMALS (one table per disease/species)

Reporting period  Intermediate report  Final report Region Total number of animals Number of animals to be tested under the programme Number of animals tested Number of animals tested individually Number of positive animals Slaughtering Indicators Number of animals with positive result slaughtered or culled Total number of animals slaughtered % coverage at animal level % positive animals Animal prevalence 1 2 3 4 5 6 7 8 9 = (4/3) × 100 10 = (6/4) × 100 Total Total — 1

Member State:

Date:

Year:

Disease:

Animal species:

ANNEX IV DATA ON VACCINATION PROGRAMMES (one table per disease/species)

Reporting period  Intermediate report  Final report Region Total number of herds Total number of animals Information on young animals vaccination programme Information on mass vaccination programme Number of herds in vaccination programme Number of herds vaccinated Number of animals vaccinated Number of doses of vaccine administered Number of herds in vaccination programme Number of herds vaccinated Number of adults vaccinated Number of young animals vaccinated Number of doses of vaccine administered 1 2 3 4 5 6 7 8 9 10 11 12 Total Total — 1

Member State:

Date:

Year:

Disease:

Species:

ANNEX V DATA ON STATUS OF HERDS AT THE END OF THE PERIOD (one table per disease/species)

Region Status of herds and animals under the programme Total number of herds and animals under the programme Unknown Not free or not officially free Free or officially free suspended Free Officially free Last check positive Last check negative Herds Animals Herds Animals Herds Animals Herds Animals Herds Animals Herds Animals Herds Animals 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Total Total — 1

Member State:

Disease:

Date:

Species:

Year:

ANNEX V.A DATA ON ZOONOTIC SALMONELLA

Reporting period  Intermediate report  Final report Type of flock Total number of flocks Total number of animals Total number of flocks under the programme Total number of animals under the programme Number of flocks checked Number of positive flocks Number of flocks depopulated Total number of animals slaughtered or destroyed Quantity of the eggs destroyed (number or kg) Quantity of eggs channelled to egg products (number or kg) Serotypes targeted in the control programme Other serotypes Serotypes targeted in the control programme Other serotypes Serotypes targeted in the control programme Other serotypes Serotypes targeted in the control programme Other serotypes Serotypes targeted in the control programme Other serotypes

Intermediate technical report

Final technical report

Member State:

Date:

Year:

Salmonella serotypes:

Animal Species:

Region:

ANNEX VI REQUIREMENTS FOR FINAL REPORTS

Minimum content of the report:

Member State:

Date:

Disease/zoonosis:

Animal species:

1. Submission of data (Annexes II, III, IV, V and Va, as appropriate)

2. Technical evaluation of the situation:

2.

2.1. Epidemiological maps for each disease/infection

2.2. Table A Information on diagnostic test used (table A): Disease/species Test Type of sample Type of test Number of tests performed

2.3. Data on infection: Disease/species Number of herds infected Number of animals infected

2.4. Table B Reasons for suspension the free or officially free status for each disease (table B): Disease/species Reason Number of herds suspended

2.5. Achievement of targets and technical difficulties

2.6. Additional epidemiological information: information on epidemiological inquiries, abortions, lesions found in abattoir or necropsy, human cases, etc.

3. Financial aspects:

3.

3.1. Completed tables of Annex VII

3.2. Overview over the money spent in the context of the programme

3.3. Detailed listing of the eligible costs.

ANNEX VII INTERMEDIATE/FINAL FINANCIAL REPORT AND PAYMENT APPLICATION (one table per disease/zoonoses/species)

Reporting period  Intermediate report  Final report Region Measures eligible for co-financing Compensation Laboratory analysis or other diagnostic test of official samples Vaccines Other (please specify) Other (please specify) 1 2 3 4 5 6 Total We certify that:

Member State:

Date:

Year:

Disease/zoonosis:

Species:

this expenditure was actually incurred, accurately accounted for and eligible under the provisions of Decision/Regulation (EC) No … (mention specific financing decision),

all supporting documents relating to the expenditure are available for inspection, notably to justify the level of compensation for animals,

no other Community contribution was requested for this programme and all revenue accruing from operations under the programme is declared to the Commission,

the programme was executed in accordance with the relevant Community legislation, in particular the rules on competition, the award of public contracts and State aid,

control procedures apply, in particular to verify the accuracy of the amounts declared, to prevent, detect and correct irregularities.

Date: ...

Name and signature of operational director: ...

ANNEX VII.A

ANNEX TO THE FINAL FINANCIAL REPORT FOR PIGS PROGRAMMES Aujesky’s disease — Classical swine fever — African swine fever — Swine vesicular disease

Region Measures eligible for co-financing Laboratory analysis and other diagnostic tests Vaccination Number of tests or laboratory analysis (type of test or analysis to be specified) Cost of tests or laboratory analysis (type of test or analysis to be specified) Number of vaccine doses and baits (type of vaccine to be specified) Cost of vaccine doses and baits (type of vaccine to be specified) Cost of distribution (type of distribution to be specified) ELISA Other (to be specified) Other (to be specified) ELISA Other (to be specified) Other (to be specified) Total 0 0 0 0,00 0,00 0,00 0 0 0,00 0,00 0,00 0,00

Member State:

Period of reference:

Year:

Species:

ANNEX VII.B

ANNEX TO THE FINAL FINANCIAL REPORT FOR BLUETONGUE PROGRAMME Bluetongue

Region Measures eligible for co-financing Laboratory analysis and other diagnostic tests Vaccination Other measures Number of tests or laboratory analysis (type of test or analysis to be specified) Cost of tests or laboratory analysis (type of test or analysis to be specified) Number of vaccine doses (type of vaccine to be specified) Cost of vaccine doses (type of vaccine to be specified) Nature of measures (please specify) Cost of measures (please specify) ELISA Other (to be specified) Other (to be specified) ELISA Other (to be specified) Other (to be specified) Traps Other Traps Other Total 0 0 0 0,00 0,00 0,00 0 0 0 0,00 0,00 0,00 0 0 0,00 0,00

Member State:

Period of reference:

Year:

Species:

ANNEX VII.C

PART 1 Bovine brucellosis — Bovine tuberculosis — Enzootic bovine leucosis ANNEX TO THE FINAL FINANCIAL REPORT FOR BOVINE PROGRAMMES

Region Measures eligible for co-financing Compensation Number of compensated animals Total cost of compensated animals Cost of animals compensated by 90 calendar days Cost of animals compensated between 91 and 120 calendar days Cost of animals compensated between 121 and 150 calendar days Cost of animals compensated between 151 and 180 calendar days Cost of animals compensated between 181 and 210 calendar days Amount received for salvage (only for BB and BT) Total 0 0,00 0,00 0,00 0,00 0,00 0,00 0,00

Member State:

Period of reference:

Year:

Species:

PART 2 Bovine brucellosis — Bovine tuberculosis — Enzootic bovine leucosis ANNEX TO THE FINAL FINANCIAL REPORT FOR BOVINE PROGRAMMES

Region Measures eligible for co-financing Laboratory analysis and other diagnostic tests Vaccination Number of tests or laboratory analysis (type of test or analysis to be specified) Cost of tests or laboratory analysis (type of test or analysis to be specified) Number of vaccine doses (type of vaccine to be specified) Cost of vaccine doses (type of vaccine to be specified) ELISA Rose Bengale Complement fixation test Tuberculin test A.G.I.D. Other (to be specified) ELISA Rose Bengale Complement fixation test Tuberculin test A.G.I.D. Other (to be specified) Total 0 0 0 0 0 0 0,00 0,00 0,00 0,00 0,00 0,00 0 0 0,00 0,00

Member State:

Period of reference:

Year:

Species:

ANNEX VII.D

PART 1 Ovine and caprine brucellosis ANNEX TO THE FINAL FINANCIAL REPORT FOR B. MELITENSIS PROGRAMME

Region Measures eligible for co-financing Compensation Number of animals by species Cost of animals by species Total cost of compensated animals Cost of animals compensated by 90 calendar days Cost of animals compensated between 91 and 120 calendar days Cost of animals compensated between 121 and 150 calendar days Cost of animals compensated between 151 and 180 calendar days Cost of animals compensated between 181 and 210 calendar days Sheep Goats Sheep Goats Total 0 0 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00

Member State:

Period of reference:

Year:

Species:

PART 2 Ovine and caprine brucellosis ANNEX TO THE FINAL FINANCIAL REPORT FOR MELITENSIS PROGRAMME

Region Measures eligible for co-financing Laboratory analysis and other diagnostic tests Vaccination Number of tests or laboratory analysis (type of test or analysis to be specified) Cost of tests or laboratory analysis (type of test or analysis to be specified) Number of vaccine doses (type of vaccine to be specified) Cost of vaccine doses (type of vaccine to be specified) Rose Bengale Complement fixation test Other (to be specified) Other (to be specified) Rose Bengale Complement fixation test Other (to be specified) Other (to be specified) Total 0 0 0 0 0,00 0,00 0,00 0,00 0 0 0,00 0,00

Member State:

Period of reference:

Year:

Species:

ANNEX VII.E

ANNEX TO THE FINAL FINANCIAL REPORT FOR RABIES PROGRAMME Rabies

Region Measures eligible for co-financing Vaccination Number of vaccine doses and baits (type of vaccine to be specified) Cost of vaccine doses and baits (type of vaccine to be specified) Cost of distribution (type of distribution to be specified) Total 0 0 0 0,00 0,00 0,00 0,00 0,00

Member State:

Period of reference:

Year:

Species:

ANNEX VII.F

PART 1 Salmonella ANNEX TO THE FINAL FINANCIAL REPORT FOR SALMONELLA PROGRAMME

Region Measures eligible for co-financing Compensation Number of animals and eggs by range of compensation Cost of animals and eggs by range of compensation Compensation made by 90 calendar days Compensation made between 91 and 120 calendar days Compensation made between 121 and 150 calendar days Compensation made between 151 and 180 calendar days Compensation made between 181 and 210 calendar days Total compensated Destroyed animals Heat-treated animals Incubated hatching eggs Destroyed non incubated hatching eggs Heat-treated non incubated hatching eggs Destroyed animals Heat-treated animals Incubated hatching eggs Destroyed non incubated hatching eggs Heat-treated non incubated hatching eggs Total 0 0 0 0 0 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0 0 0,00 0,00

Member State:

Period of reference:

Year:

Species:

PART 2 Salmonella ANNEX TO THE FINAL FINANCIAL REPORT FOR SALMONELLA

Region Measures eligible for co-financing Laboratory analysis and other diagnostic tests Vaccination Number of bacteriological tests (type of test to be specified) Cost of bacteriological tests (type of test to be specified) Number of vaccine doses (type of vaccine to be specified) Cost of vaccine doses (type of vaccine to be specified) Total 0 0 0 0,00 0,00 0,00 0 0 0,00 0,00

Member State:

Period of reference:

Year:

Species:

ANNEX VIII INTERMEDIATE/FINAL TECHNICAL AND FINANCIAL REPORT AND PAYMENT APPLICATIONS Table A Table B

Reporting period  Intermediate report  Final report TSE Monitoring Member State: Year: Tests on bovine animals Number of tests Unit cost Total cost Tests on animals referred to in Annex III, Chapter A, Part I, points 2.1.3 and 4 to Regulation (EC) No 999/2001 of the European Parliament and of the Council Tests on animals referred to in Annex III, Chapter A, Part I, points 2.2 to Regulation (EC) No 999/2001 Total Tests on ovine animals Number of tests Unit cost Total cost Tests on animals referred to in Annex III, Chapter A, Part II, point 2 to Regulation (EC) No 999/2001 Tests on animals referred to in Annex III, Chapter A, Part II, point 3 to Regulation (EC) No 999/2001 Tests on animals referred to in Annex III, Chapter A, Part II, point 5 to Regulation (EC) No 999/2001 Tests performed according to the different requirements of Annex VII, Chapter A to Regulation (EC) No 999/2001 Others (specify) Total Tests on caprine animals Number of tests Unit cost Total cost Tests on animals referred to in Annex III, Chapter A, Part II, point 2 to Regulation (EC) No 999/2001 Tests on animals referred to in Annex III, Chapter A, Part II, point 3 to Regulation (EC) No 999/2001 Tests on animals referred to in Annex III, Chapter A, Part II, point 5 to Regulation (EC) No 999/2001 Tests performed according to the different requirements of Annex VII, Chapter A to Regulation (EC) No 999/2001 Others (specify) Tests on animals of other species Tests on animals of other species (specify separately each species) Total Genotyping Number of tests Unit cost Total cost Genotyping of animals referred to in Annex III, Chapter A, Part II, point 8.1 to Regulation (EC) No 999/2001 Genotyping of animals referred to in Annex III, Chapter A, Part II, point 8.2 to Regulation (EC) No 999/2001 Primary molecular testing with a discriminatory immuno-blotting Number of tests Unit cost Total cost Tests on animals referred to in Annex X, Chapter C, point 3.2(c)(i) to Regulation (EC) No 999/2001 TSE Eradication Member State: Month: Year: BSE culling Number of animals Unit cost Total cost Animals killed under the requirements of Annex VII, Chapter A, point 2.1 to Regulation (EC) No 999/2001 Scrapie Culling Number of animals Unit cost Total cost Animals killed under the requirements of Annex VII, Chapter A to Regulation (EC) No 999/2001 Genotyping Number of tests Unit cost Total cost Animals genotyped under the requirements of Annex VII, Chapter A, point 2.3 to Regulation (EC) No 999/2001 Ewes genotyped under the framework of a breeding programme referred to in Article 6a of Regulation (EC) No 999/2001 Rams genotyped under the framework of a breeding programme referred to in Article 6a of Regulation (EC) No 999/2001 Total We certify that:

Member State:

Date:

Year:

Disease:

this expenditure was actually incurred, accurately accounted for and eligible under the provisions of Decision/Regulation (EC) No … (mention specific financing decision),

all supporting documents relating to the expenditure are available for inspection, notably to justify the level of compensation for animals,

no other Community contribution was requested for this programme and all revenue accruing from operations under the programme is declared to the Commission,

the programme was executed in accordance with the relevant Community legislation, in particular the rules on competition, the award of public contracts and state aid,

control procedures apply, in particular to verify the accuracy of the amounts declared, to prevent, detect and correct irregularities.

Date: …

Name and signature of operational director: …

ANNEX IX INTERMEDIATE/FINAL TECHNICAL AND FINANCIAL REPORT AND PAYMENT APPLICATIONS

Reporting period  Intermediate report  Final report

Member State:

Date:

Year:

Disease:

Species:

PART A Table 1 Table 2 Table 3 Poultry holdings (except ducks and geese) sampled Serological investigation according to point B of Annex I to Commission Decision 2007/268/EC on holdings of broilers (only when at risk)/fattening turkeys/chicken breeders/turkey breeders/laying hens/free range laying hens/ratites/farmed feathered game (pheasants, partridges, quails …)/backyard flocks/others (keep as appropriate) PLEASE USE ONE FORM PER POULTRY CATEGORY Duck and geese holdings sampled according to point C of Annex I to Decision 2007/268/EC Serological investigation Wild birds — investigation according to the surveillance programme for avian influenza in wild birds set out in Annex II to Decision 2007/268/EC

TECHNICAL REPORT NUTS 2 code Total number of holdings Total number of holdings sampled Number of samples per holding Total number of tests performed per method Methods of laboratory analysis Total NUTS 2 code Total number of duck and geese holdings Total number of duck and geese holdings sampled Number of samples per holding Total number of tests performed per method Methods of laboratory analysis Total NUTS 2 code Total number of birds sampled Total number of samples taken for active surveillance Total number of samples taken for passive surveillance Total

PART B Avian influenza

FINANCIAL REPORT Region Measures eligible for co-financing Laboratory analysis and other diagnostic tests Sampling Number of laboratory tests Cost of laboratory tests Number of samples of wild birds ELISA AGID HI for H5/H7 Virus isolation PCR Other (to be specified) ELISA AGID HI for H5/H7 Virus isolation PCR Other (to be specified) Total 0 0 0 0 0 0 0,00 0,00 0,00 0,00 0,00 0,00 0,00 We certify that:

Member State: …

Period of reference: …

Year: …

Species: …

this expenditure was actually incurred, accurately accounted for and eligible under the provisions of Decision/Regulation (EC) No … (mention specific financing decision),

all supporting documents relating to the expenditure are available for inspection, notably to justify the level of compensation for animals,

no other Community contribution was requested for this programme and all revenue accruing from operations under the programme is declared to the Commission,

the programme was executed in accordance with the relevant Community legislation, in particular the rules on competition, the award of public contracts and State aid,

control procedures apply, in particular to verify the accuracy of the amounts declared, to prevent, detect and correct irregularities.

Date: …

Name and signature of operational director: …

ANNEX X INTERMEDIATE/FINAL TECHNICAL AND FINANCIAL REPORT

Reporting period  Intermediate report  Final report We certify that:

Member State:

Date:

Year:

Disease:

Species:

PART A 1.1.1.1.2.1.3. 2.2.1.2.2.2.3. 3. 4.

TECHNICAL REPORT Diseases Fish  VHS  IHN  ISA  KHV Molluscs  Marteilia refringens  Bonamia ostrae Crustaceans  White spot disease General information on the programmes Competent Authority Organisation, supervision of all stakeholders involved in the programme Duration of the programme Data on testing animals Farm or mollusc farming area Number of samplings Number of clinical inspections Water temperature at sampling/Inspection Species at sampling Species sampled Number of animals sampled (total and by species) Number of tests Positive results of laboratorial examination Positive results of clinical inspections Total Total Data on testing farms or farming areas Member State, Zone or Compartment Total number of farms or mollusc farming areas Total number farms or mollusc farming areas under the programme Number of farms or mollusc farming areas checked Number of positive farms or mollusc farming areas Number of new positive farms or mollusc farming areas Number of farms or mollusc farming areas depopulated % positive farms or mollusc farming areas depopulated Animals removed and disposed of TARGET INDICATORS % farms or mollusc farming areas coverage % positive farms or mollusc farming areas period farms or mollusc farming areas prevalence % new positive farms or mollusc farming areas farms or mollusc farming areas incidence 1 2 3 4 5 6 7 8 = (7/5) × 100 9 10 = (4/3) × 100 11 = (5/4) × 100 12 = (6/4) × 100 Total

Member State, Zone or Compartment

Disease:

Year:

Disease:

Year:

PART B Table A 1.1.1.1.2.1.3.2.2.1.2.2.2.3.2.4.3.3.1.3.2.3.3.3.4.3.5.4.5.6.7. Detailed analysis of the cost of the programme

FINANCIAL REPORT Costs related to Specification Number of units Unitary cost in EUR Total amount in EUR Community funding requested (yes/no) Testing Cost of the analysis Test: Test: Test: Cost of sampling Other costs Vaccination or treatment Purchase of vaccine/treatment Distribution costs Administering costs Control costs Removal and disposal of the aquaculture animals Compensation of animals Transport costs Disposal costs Loss in case of removal Costs from treatment of products Cleansing and disinfection Salaries (staff contracted for the programme only) Consumables and specific equipment Other costs Total

this expenditure was actually incurred, accurately accounted for and eligible under the provisions of Decision/Regulation (EC) No … (mention specific financing decision),

all supporting documents relating to the expenditure are available for inspection, notably to justify the level of compensation for animals,

no other Community contribution was requested for this programme and all revenue accruing from operations under the programme is declared to the Commission,

the programme was executed in accordance with the relevant Community legislation, in particular the rules on competition, the award of public contracts and State aid,

control procedures apply, in particular to verify the accuracy of the amounts declared, to prevent, detect and correct irregularities.

Date: …

Name and signature of operational director: …

Versions

  1. 2008-10-21

Cited by